Ozurdex

This page shows the latest Ozurdex news and features for those working in and with pharma, biotech and healthcare.

NICE backs Bayer's Eylea in diabetic eye condition

NICE backs Bayer's Eylea in diabetic eye condition. TheInstitute also recommends Allergan's Ozurdex in final guidance. ... Bayer's Eylea and Allergan's Ozurdex have been recommended for use on the NHS in England to treat diabetic macular oedema (DMO).

Latest news

NICE recommends Ozurdex for diabetic eye condition

NICE recommends Ozurdex for diabetic eye condition. Draft guidance cites implant as option for patients with diabetic macular oedema. ... Ozurdex is injected into the eye once every six months and works by suppressing inflammation and preventing oedema
Fresh approval for Roche's Lucentis as competition heats up

Roche's drug is being challenged in the market by Bayer's Eylea (aflibercept) as well as newer entrants such as Allergan's Ozurdex (intravitreal dexamethasone).
New eye indication for Allergan’s Ozurdex

New eye indication for Allergan’ s Ozurdex. EU approval extends the drug's use to diabetic macular oedema. ... Ozurdex joins a competitive market for DMO, with approved drugs in the EU including Novartis' Lucentis (ranibizumab).
Allergan will start phase III DARPin trials next year

On the plus side, Allergan said the FDA had approved a new indication for its intravitreal implant Ozurdex (dexamethasone), namely the treatment of diabetic macular oedema (DME) in adults who have
NICE against new indication for Novartis' Lucentis

Its draft guidance concluded the ICER for Lucentis in central RVO versus Allergan's Ozurdex (dexamethasone) intravitreal implant, the currently approved treatment, was likely to be over £37, 400 per QALY ... Ozurdex was recommended by NICE earlier this

More from news
Approximately 3 fully matching, plus 5 partially matching documents found.

Latest Intelligence

Allergan and taking a specialised approach

spasticity associated with stroke and for the ophthalmology treatment Ozurdex in diabetic macular oedema.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Associate Medical Director: Highly Competitive

Medical Writers: Competitive Salary and Benefits

Senior Systematic Review Analyst - Oxford: Negotiable

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Medical Writers Required – Cheshire: DOE

Senior Medical Writer: Great salary and benefits

Senior Account Executive, London, Medical Communications: Excellent package

Scientific Director / Editorial Team Leader: Great salary and benefits

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Production Manager – Healthcare Communications: DOE

Account Manager / Account Director: Competative

Account Director: £48, 000 - £60, 000

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Client Services Director – Medical Education Agency – North West...: Salary TBC

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Consultant Health Economics - London / Oxford: Negotiable

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Associate Editorial Director – Med Comms – London: Salary TBC

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Subscribe to our email news alerts

PMHub

Add my company

emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...